<--- Back to Details
First PageDocument Content
Economy / Biopeople / Biotechnology / Novo Nordisk / Regulatory science / Business / Technology
Date: 2015-11-20 04:15:30
Economy
Biopeople
Biotechnology
Novo Nordisk
Regulatory science
Business
Technology

Vedr test af skabelonsystem

Add to Reading List

Source URL: pharmacy.ku.dk

Download Document from Source Website

File Size: 351,68 KB

Share Document on Facebook

Similar Documents

ABLYNX ACHIEVES FIRST MILESTONE AS PART OF COLLABORATION WITH NOVO NORDISK   Multi-specific Nanobody candidate reached discovery milestone Ablynx to receive a €1 million success fee

DocID: 1thLm - View Document

Economy / Biopeople / Biotechnology / Novo Nordisk / Regulatory science / Business / Technology

Vedr test af skabelonsystem

DocID: 1rjCQ - View Document

Economy / Business / Finance / Novo Nordisk / Sanofi / University of Connecticut / Venture capital

SECT Tech Summary SECT Tech, LLC is an existing team of accomplished bioscience executives with complementary backgrounds and is part of the State of Connecticut’s CTNext economic development program (administered by C

DocID: 1qPhd - View Document

Novo Nordisk Fonden bevilliger 235 million kroner til forskning i stamceller Pressemeddelelse, 23. november, 2015 Novo Nordisk Fonden har bevilget 235 millioner kroner til styrkelse og udvidelse af Novo Nordisk Foundatio

DocID: 1qJz7 - View Document

Novo Nordisk / RSVP / Biotechnology / Economy of Denmark / Business

Dear Friends, Our next meeting will be held at a new restaurant, Duplex, please note the following information: Date/Time: Wednesday, Dec 05, 2012, at 6:30 p.m. Location: Duplex Restaurant 8722 West 3rd St. Los Angeles,

DocID: 1pXal - View Document